Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How common is diabetic nephropathy?

G V Gill1

  • 1Arrowe Park Hospital, Wirral, Merseyside, UK.

Diabetes Research (Edinburgh, Scotland)
|April 1, 1989
PubMed
Summary
This summary is machine-generated.

Diabetic nephropathy prevalence is lower than expected, with only 2.1% of patients showing definite signs. Early kidney damage may impact survival rates before established diabetic nephropathy develops.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease and survival on the Thai-Burma railway: lessons for modern tropical medicine?

QJM : monthly journal of the Association of Physicians·2018
Same author

Flight Lieutenant Peach's observations on Burning Feet Syndrome in Far Eastern Prisoners of War 1942-45.

QJM : monthly journal of the Association of Physicians·2017
Same author

Diazoxide for the treatment of hypoglycaemic dumping syndrome.

QJM : monthly journal of the Association of Physicians·2011
Same author

The outcome of brittle type 1 diabetes--a 20 year study.

QJM : monthly journal of the Association of Physicians·2011
Same author

Long-term glycaemic outcome of structured nurse-led diabetes care in rural Africa.

QJM : monthly journal of the Association of Physicians·2011
Same author

Nurse-led cardiovascular risk factor intervention leads to improvements in cardiovascular risk targets and glycaemic control in people with Type 1 diabetes when compared with routine diabetes clinic attendance.

Diabetic medicine : a journal of the British Diabetic Association·2011
Same journal

Hypoglycemic activity of an indigenous plant material.

Diabetes research (Edinburgh, Scotland)·1994
Same journal

Insulinotropic action of meglitinide analogs: concentration-response relationship and nutrient dependency.

Diabetes research (Edinburgh, Scotland)·1994
Same journal

Erythrocyte, plasma total, ultrafiltrable and platelet magnesium in type 2 (non-insulin dependent) diabetes mellitus.

Diabetes research (Edinburgh, Scotland)·1994
Same journal

Ionophoretic activity of meglitinide analogues.

Diabetes research (Edinburgh, Scotland)·1994
Same journal

The effects of chronic diabetes and physiological insulin concentration on ketone bodies metabolism in the heart.

Diabetes research (Edinburgh, Scotland)·1994
Same journal

Insulinotropic action of the D-glucosyl and 3-O-methyl-D-glucosyl monomethyl esters of succinic acid.

Diabetes research (Edinburgh, Scotland)·1994
See all related articles

Area of Science:

  • Nephrology
  • Endocrinology
  • Diabetology

Background:

  • Diabetic nephropathy is a major complication of diabetes mellitus.
  • Previous estimates suggest a higher prevalence of overt nephropathy.

Purpose of the Study:

  • To determine the prevalence of definite diabetic nephropathy in a diabetic clinic population.
  • To investigate potential reasons for lower-than-expected prevalence.

Main Methods:

  • A retrospective study of 1,356 diabetic patients over 12 months.
  • Application of strict diagnostic criteria for definite diabetic nephropathy.

Main Results:

  • Only 28 patients (2.1%) met the criteria for definite diabetic nephropathy.
  • The observed prevalence is lower than previously reported figures.

Related Experiment Videos

Conclusions:

  • The prevalence of overt diabetic nephropathy may be overestimated in prior reports.
  • High mortality in patients with early kidney damage (microalbuminuria/proteinuria) might explain the lower observed prevalence of established disease.